Andreas Halvorsen - Viking Global Investors
Holding/activity history for Kinnate Biopharma Inc (KNTE)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q2 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2024 Q1 | 1,820,462 | 0.02 | $2.66 | $4,842,429 | SEC | ||
| 2023 Q4 | 1,820,462 | 0.02 | $2.37 | $4,314,495 | SEC | ||
| 2023 Q3 | 1,820,462 | 0.01 | $1.40 | $2,548,647 | SEC | ||
| 2023 Q2 | 1,820,462 | 0.02 | $3.03 | $5,516,000 | SEC | ||
| 2023 Q1 | 1,820,462 | 0.05 | $6.25 | $11,377,888 | SEC | ||
| 2022 Q4 | 1,820,462 | 0.06 | $6.10 | $11,104,818 | SEC | ||
| 2022 Q3 | 1,820,462 | 0.10 | $11.95 | $21,755,000 | SEC | ||
| 2022 Q2 | 1,820,462 | 0.11 | $12.61 | $22,956,000 | SEC | ||
| 2022 Q1 | 1,820,462 | 0.08 | $11.26 | $20,498,000 | SEC | ||
| 2021 Q4 | 1,820,462 | 0.09 | $17.72 | $32,259,000 | SEC | ||
| 2021 Q3 | 1,820,462 | 0.12 | $23.02 | $41,907,000 | SEC | ||
| 2021 Q2 | 1,820,462 | 0.13 | Reduce 2.75% | <0.01 | $23.28 | $42,380,000 | SEC |
| 2021 Q1 | 1,872,023 | 0.17 | $31.16 | $58,332,000 | SEC | ||
| 2020 Q4 | 1,872,023 | 0.21 | Buy | 0.21 | $39.78 | $74,469,000 | SEC |